Blood test breakthrough could spot severe diverticulitis early

NCT ID NCT07322926

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 101 patients with acute diverticulitis to see if routine blood tests could tell apart mild and severe cases. Researchers compared lab results like white blood cell count and C-reactive protein between the two groups. The goal was to find simple markers that help doctors decide who needs more aggressive treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could help doctors quickly identify which diverticulitis patients need more urgent care using routine blood tests.

What could go wrong

This is a small, retrospective study that only looks back at past data. The results need to be confirmed in larger, more diverse groups before they can be used in practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIVERTICULITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diverticulitis Emergencies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Haydarpasa Numune Research and Training Hospital

    Istanbul, 34668, Turkey (Türkiye)